openPR Logo
Press release

ENovate Biolife Targets African Market

09-09-2011 08:30 AM CET | Health & Medicine

Press release from: enovatebiolife

Salt Lake City, Utah (Sept 10, 2011) – ENovate Biolife LLC is pleased to announce their participation at Medexpo Kenya 2011 at Nairobi. The Medexpo Kenya will take place on 17-19 September 2011 at Sarit Centre. Medexpo Kenya is the prime event in the region attracting visitors from all over East & Central Africa displaying vast range of products from Hospital Supplies, Medical Equipment, Dental Equipment, Healthcare supplements and Pharmaceuticals. The Event would take place in conjunction with Kenya Trade Show 2011.

ENovate will be promoting its five clinically proven healthcare supplements at the Expo: Three of the products are ready for marketing; LancononeTM – a unique glucosamine free combination to support joint mobility and overall joint health; HeezOn® - a novel non-hormonal blend to enhance male sexual health; and Lithocap – a unique blend to promote kidney health. Two other formulations for Rhinitis and Sleep are in trial stages and will be launching soon.
Africa is one of the major emerging markets in nutraceutical industry and this expo provides us the best platform to meet industry veterans from the various countries and introduce our products.” says Dr. Diwakar Jha, Head of International Business at ENovate Biolife

About ENovate Biolife
ENovate Biolife LLC discovers and develops novel Botanical Drugs and Healthcare Products. A focused scientific development strategy helps to reduce research and development cost and save time without compromising on safety and efficacy.

Contact us at:
ENOVATE BIOLIFE LLC. www.enovatebiolife.com, customerservice@enovatebiolife.com

ENovate Biolife LLC discovers and develops novel Botanical Drugs and Healthcare Products. A focused scientific development strategy helps to reduce research and development cost and save time without compromising on safety and efficacy.

B-117, Morya House, Andheri West, Mumbai - 400053

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ENovate Biolife Targets African Market here

News-ID: 190977 • Views: 1488

More Releases from enovatebiolife

ENovate Biolife announces start of Clinical Study for Rhinitis
For Immediate Release California, July 20, 2011: ENovate Biolife, a specialty healthcare company, announced today that it has initiated a Phase IIa clinical trial with its lead product E-RH-06 in subjects with Rhinitis. ENovate Biolife has received ethics committee approval for safety and dose determining study for investigational product E-RH-06 for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea. Rhinitis (allergic or non allergic) is a clinical problem
Enovate Biolife enters the Filipino Supplement Market
Enovate Biolife signed a collaboration agreement with Manila-based MP-AIMM Marketing Corporation to enter the Philippines Supplements Market. For Immediate Release Redwood City, CA, June 15, 2011: The research products of Enovate Biolife will be now available in Philippines through the distribution channel of MP-AIMM Marketing Corporation. The company has tied-up with AIMM, marketing various products and services with distribution networks all over the country. “We are pleased to partner with
ENovate Biolife Targets Asia-Pacific Markets
Salt Lake City, Utah (July 20, 2011) – ENovate Biolife LLC is pleased to announce their participation at Natural Products Expo Asia 2011 in Hong Kong. The 9th Natural Products Expo Asia (www.naturalproductsasia.com) will take place at the Hong Kong Convention and Exhibition Centre on 25 – 27 August 2011. It is the premier sourcing trade show for Asia’s natural, organic and healthy products industry, attracting over 350 exhibitors and
Joint Health Supplement
Salt Lake City, Utah (July 19, 2011) – ENovate Biolife LLC, announced the launch of its clinically documented supplement for joint health ‘Lanconone’. Lanconone is popular worldwide and is now available online in the US. Lanconone is an all natural formula tested to deliver greater joint flexibility and facilitate walking, bending, climbing, gardening and other everyday activities. Lanconone is manufactured under Gold standards using standardized ingredients to give fast and

All 5 Releases


More Releases for ENovate

Medical Computer Cart Market 2019: Ergotron, Capsa Solutions, Enovate, InterMetr …
The Medical Computer Cart is expected to grow at a CAGR of roughly 9.3% over the next five years, will reach 510 million US$ in 2024, from 300 million US$ in 2019, according to a new study. Get Sample Copy of this Report at @ https://www.orianresearch.com/request-sample/855682 Medical computer carts can be defined as medical carts used by medical staff for several day
Global Medical Computer Cart Industry Depth Research Report 2023 (Enovate medica …
The point of a medical computer cart is to facilitate the workload of nurses alongside other medical professionals, subsequently increasing patient care and safety. Medical computer carts form an crucial part of medical aid, as they encourage bedside patient care through their capacity to record, store, and dispense equipment, supplies, pharmaceuticals, patient information, and related data. Medical Computer Carts market is showing great development over the recent years. The development in
Medical Computer Cart Market 2017- Ergotron, Capsa Solutions, Enovate, JACO
Medical Computer Cart Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Medical Computer Cart is designed to ease the workload for nurses and other healthcare professionals, as well as to enhance patient care. Medical computer carts are used in a variety of application including charting and EMR, medication dispensing,
ENovate Biolife reports encouraging results for their Rhinitis Product
ENovate Biolife, a specialty healthcare company, announced new data showing how the company’s lead investigational product E-RH-06 will work for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea. Acute or chronic inflammation of nasal mucous membrane is a hallmark of rhinitis, which may be caused by viruses, bacteria or irritants. The inflammation results in the generation of excessive amounts of mucus, nasal congestion, sneezing and itchiness
ENovate Biolife announces start of Clinical Study for Rhinitis
For Immediate Release California, July 20, 2011: ENovate Biolife, a specialty healthcare company, announced today that it has initiated a Phase IIa clinical trial with its lead product E-RH-06 in subjects with Rhinitis. ENovate Biolife has received ethics committee approval for safety and dose determining study for investigational product E-RH-06 for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea. Rhinitis (allergic or non allergic) is a clinical problem
Enovate Biolife enters the Filipino Supplement Market
Enovate Biolife signed a collaboration agreement with Manila-based MP-AIMM Marketing Corporation to enter the Philippines Supplements Market. For Immediate Release Redwood City, CA, June 15, 2011: The research products of Enovate Biolife will be now available in Philippines through the distribution channel of MP-AIMM Marketing Corporation. The company has tied-up with AIMM, marketing various products and services with distribution networks all over the country. “We are pleased to partner with